{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:57:37Z","timestamp":1793743057357,"version":"4.6.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"7965","license":[{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2023,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Rapidly evolving influenza A viruses (IAVs) and influenza B viruses (IBVs) are major causes of recurrent lower respiratory tract infections.\u00a0Current influenza vaccines elicit antibodies predominantly to the highly variable head\u00a0region of haemagglutinin and their effectiveness is limited by viral drift\n                    <jats:sup>1<\/jats:sup>\n                    and suboptimal immune responses\n                    <jats:sup>2<\/jats:sup>\n                    . Here we describe a neuraminidase-targeting monoclonal antibody, FNI9, that potently inhibits the enzymatic activity of all group 1 and group 2 IAVs, as well as Victoria\/2\/87-like, Yamagata\/16\/88-like and ancestral\u00a0IBVs. FNI9 broadly neutralizes seasonal IAVs and IBVs, including the immune-evading H3N2 strains bearing an N-glycan at position 245, and shows synergistic activity when combined with anti-haemagglutinin stem-directed antibodies. Structural analysis reveals that D107 in the FNI9 heavy chain complementarity-determinant region 3 mimics the interaction of the sialic acid carboxyl group with the three highly conserved arginine residues (R118, R292 and R371) of the neuraminidase catalytic site. FNI9 demonstrates potent prophylactic activity against lethal IAV and IBV infections in mice. The unprecedented breadth and potency of the FNI9 monoclonal antibody supports its development for the prevention of influenza illness by seasonal and pandemic viruses.\n                  <\/jats:p>","DOI":"10.1038\/s41586-023-06136-y","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T12:04:45Z","timestamp":1685534685000},"page":"590-597","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["A pan-influenza antibody inhibiting neuraminidase via receptor mimicry"],"prefix":"10.1038","volume":"618","author":[{"given":"Corey","family":"Momont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha V.","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizia","family":"Zatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9343-127X","authenticated-orcid":false,"given":"Julia","family":"di Iulio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Minola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Czudnochowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin","family":"Branch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Donermeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhant","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2620-5066","authenticated-orcid":false,"given":"Alex","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Guarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail E.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8282-7658","authenticated-orcid":false,"given":"Roberto","family":"Spreafico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8567-3501","authenticated-orcid":false,"given":"Samantha S.","family":"Yim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale R.","family":"Balce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istvan","family":"Bartha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Meury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan I.","family":"Croll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0619-7487","authenticated-orcid":false,"given":"David M.","family":"Belnap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1137-9322","authenticated-orcid":false,"given":"Michael A.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Timothy","family":"Schaiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Cameroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6290-7677","authenticated-orcid":false,"given":"Amalio","family":"Telenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert W.","family":"Virgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8030-0219","authenticated-orcid":false,"given":"Laura E.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9565-2030","authenticated-orcid":false,"given":"Lisa A.","family":"Purcell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lanzavecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1475-659X","authenticated-orcid":false,"given":"Gyorgy","family":"Snell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5797-1364","authenticated-orcid":false,"given":"Davide","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5776-654X","authenticated-orcid":false,"given":"Matteo Samuele","family":"Pizzuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"key":"6136_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28706-1","volume":"8","author":"E Kirkpatrick","year":"2018","unstructured":"Kirkpatrick, E., Qiu, X., Wilson, P. C., Bahl, J. & Krammer, F. The influenza virus hemagglutinin head evolves faster than the stalk domain. Sci. Rep. 8, 10432 (2018).","journal-title":"Sci. Rep."},{"key":"6136_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1056\/NEJMp1714916","volume":"378","author":"CI Paules","year":"2018","unstructured":"Paules, C. I., Sullivan, S. G., Subbarao, K. & Fauci, A. S. Chasing seasonal influenza\u2014the need for a universal influenza vaccine. N. Engl. J. Med. 378, 7\u20139 (2018).","journal-title":"N. Engl. J. Med."},{"key":"6136_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S2213-2600(18)30496-X","volume":"7","author":"GBD 2017 Influenza Collaborators.","year":"2019","unstructured":"GBD 2017 Influenza Collaborators. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017. Lancet Respir. Med. 7, 69\u201389 (2019).","journal-title":"Lancet Respir. Med."},{"key":"6136_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/tropicalmed4020072","volume":"4","author":"K Subbarao","year":"2019","unstructured":"Subbarao, K. The critical interspecies transmission barrier at the animal\u2013human interface. Trop. Med. Infect. Dis. 4, 72 (2019).","journal-title":"Trop. Med. Infect. Dis."},{"key":"6136_CR5","doi-asserted-by":"publisher","first-page":"104970","DOI":"10.1016\/j.antiviral.2020.104970","volume":"185","author":"H Zaraket","year":"2021","unstructured":"Zaraket, H., Hurt, A. C., Clinch, B., Barr, I. & Lee, N. Burden of influenza B virus infection and considerations for clinical management. Antiviral Res. 185, 104970 (2021).","journal-title":"Antiviral Res."},{"key":"6136_CR6","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.cmi.2016.07.007","volume":"22","author":"A Gaymard","year":"2016","unstructured":"Gaymard, A., Le Briand, N., Frobert, E., Lina, B. & Escuret, V. Functional balance between neuraminidase and haemagglutinin in influenza viruses. Clin. Microbiol. Infect. 22, 975\u2013983 (2016).","journal-title":"Clin. Microbiol. Infect."},{"key":"6136_CR7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","volume":"69","author":"JJ Skehel","year":"2000","unstructured":"Skehel, J. J. & Wiley, D. C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69, 531\u2013569 (2000).","journal-title":"Annu. Rev. Biochem."},{"key":"6136_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fmicb.2019.00039","volume":"10","author":"JL McAuley","year":"2019","unstructured":"McAuley, J. L., Gilbertson, B. P., Trifkovic, S., Brown, L. E. & McKimm-Breschkin, J. L. Influenza virus neuraminidase structure and functions. Front. Microbiol. 10, 39 (2019).","journal-title":"Front. Microbiol."},{"key":"6136_CR9","doi-asserted-by":"publisher","first-page":"12665","DOI":"10.1128\/JVI.78.22.12665-12667.2004","volume":"78","author":"MN Matrosovich","year":"2004","unstructured":"Matrosovich, M. N., Matrosovich, T. Y., Gray, T., Roberts, N. A. & Klenk, H. D. Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J. Virol. 78, 12665\u201312667 (2004).","journal-title":"J. Virol."},{"key":"6136_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-321","volume":"10","author":"M Cohen","year":"2013","unstructured":"Cohen, M. et al. Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase. Virol. J. 10, 321 (2013).","journal-title":"Virol. J."},{"key":"6136_CR11","doi-asserted-by":"publisher","first-page":"e1007233","DOI":"10.1371\/journal.ppat.1007233","volume":"14","author":"H Guo","year":"2018","unstructured":"Guo, H. et al. Kinetic analysis of the influenza A virus HA\/NA balance reveals contribution of NA to virus-receptor binding and NA-dependent rolling on receptor-containing surfaces. PLoS Pathog. 14, e1007233 (2018).","journal-title":"PLoS Pathog."},{"key":"6136_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.tim.2019.08.010","volume":"28","author":"E de Vries","year":"2020","unstructured":"de Vries, E., Du, W., Guo, H. & de Haan, C. A. M. Influenza A virus hemagglutinin-neuraminidase-receptor balance: preserving virus motility. Trends Microbiol. 28, 57\u201367 (2020).","journal-title":"Trends Microbiol."},{"key":"6136_CR13","doi-asserted-by":"publisher","first-page":"19123","DOI":"10.1073\/pnas.0607614103","volume":"103","author":"A Harris","year":"2006","unstructured":"Harris, A. et al. Influenza virus pleiomorphy characterized by cryoelectron tomography. Proc. Natl Acad. Sci. USA 103, 19123\u201319127 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"6136_CR14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S0140-6736(73)92196-X","volume":"1","author":"AS Monto","year":"1973","unstructured":"Monto, A. S. & Kendal, A. P. Effect of neuraminidase antibody on Hong Kong influenza. Lancet 1, 623\u2013625 (1973).","journal-title":"Lancet"},{"key":"6136_CR15","doi-asserted-by":"publisher","first-page":"e00417-16","DOI":"10.1128\/mBio.00417-16","volume":"7","author":"MJ Memoli","year":"2016","unstructured":"Memoli, M. J. et al. Evaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A\/H1N1 virus healthy human challenge model. mBio 7, e00417-16 (2016).","journal-title":"mBio"},{"key":"6136_CR16","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/infdis\/jis935","volume":"207","author":"RB Couch","year":"2013","unstructured":"Couch, R. B. et al. Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase. J. Infect. Dis. 207, 974\u2013981 (2013).","journal-title":"J. Infect. Dis."},{"key":"6136_CR17","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1093\/cid\/ciz639","volume":"70","author":"HE Maier","year":"2020","unstructured":"Maier, H. E. et al. Pre-existing antineuraminidase antibodies are associated with shortened duration of influenza A(H1N1)pdm virus shedding and illness in naturally infected adults. Clin. Infect. Dis. 70, 2290\u20132297 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"6136_CR18","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1172\/JCI84428","volume":"126","author":"DJ DiLillo","year":"2016","unstructured":"DiLillo, D. J., Palese, P., Wilson, P. C. & Ravetch, J. V. Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection. J. Clin. Invest. 126, 605\u2013610 (2016).","journal-title":"J. Clin. Invest."},{"key":"6136_CR19","doi-asserted-by":"publisher","first-page":"e02332-17","DOI":"10.1128\/mBio.02332-17","volume":"9","author":"F Krammer","year":"2018","unstructured":"Krammer, F. et al. NAction! How can neuraminidase-based immunity contribute to better influenza virus vaccines? mBio 9, e02332-17 (2018).","journal-title":"mBio"},{"key":"6136_CR20","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1128\/AAC.00352-20","volume":"64","author":"JJ Lim","year":"2020","unstructured":"Lim, J. J. et al. A phase 2 randomized, double-blind, placebo-controlled trial of MHAA4549A, a monoclonal antibody, plus oseltamivir in patients hospitalized with severe influenza A virus infection. Antimicrob. Agents Chemother. 64, 1285\u20131210 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"6136_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.00694-18","volume":"62","author":"SO Ali","year":"2018","unstructured":"Ali, S. O. et al. Evaluation of MEDI8852, an anti-influenza A monoclonal antibody, in treating acute uncomplicated influenza. Antimicrob. Agents Chemother. 62, 1\u201347 (2018).","journal-title":"Antimicrob. Agents Chemother."},{"key":"6136_CR22","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05567783 (2022)."},{"key":"6136_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34521-0","volume":"13","author":"A Yasuhara","year":"2022","unstructured":"Yasuhara, A. et al. A broadly protective human monoclonal antibody targeting the sialidase activity of influenza A and B virus neuraminidases. Nat. Commun. 13, 6602 (2022).","journal-title":"Nat. Commun."},{"key":"6136_CR24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1126\/science.aay0678","volume":"366","author":"D Stadlbauer","year":"2019","unstructured":"Stadlbauer, D. et al. Broadly protective human antibodies that target the active site of influenza virus neuraminidase. Science 366, 499\u2013504 (2019).","journal-title":"Science"},{"key":"6136_CR25","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.immuni.2020.08.015","volume":"53","author":"A Madsen","year":"2020","unstructured":"Madsen, A. et al. Human antibodies targeting influenza B virus neuraminidase active site are broadly protective. Immunity 53, 852\u2013863.e7 (2020).","journal-title":"Immunity"},{"key":"6136_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cell.2018.03.030","volume":"173","author":"YQ Chen","year":"2018","unstructured":"Chen, Y. Q. et al. Influenza infection in humans induces broadly cross-reactive and protective neuraminidase-reactive antibodies. Cell 173, 417\u2013429.e10 (2018).","journal-title":"Cell"},{"key":"6136_CR27","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1056\/NEJMc1111078","volume":"365","author":"AC Hurt","year":"2011","unstructured":"Hurt, A. C. et al. Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza. N. Engl. J. Med. 365, 2541\u20132542 (2011).","journal-title":"N. Engl. J. Med."},{"key":"6136_CR28","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3201\/eid1504.181280","volume":"15","author":"A Meijer","year":"2009","unstructured":"Meijer, A. et al. Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007\u201308 season. Emerg. Infect. Dis. 15, 552\u2013560 (2009).","journal-title":"Emerg. Infect. Dis."},{"key":"6136_CR29","doi-asserted-by":"publisher","first-page":"e1008411","DOI":"10.1371\/journal.ppat.1008411","volume":"16","author":"H Powell","year":"2020","unstructured":"Powell, H. & Pekosz, A. Neuraminidase antigenic drift of H3N2 clade 3c.2a viruses alters virus replication, enzymatic activity and inhibitory antibody binding. PLoS Pathog. 16, e1008411 (2020).","journal-title":"PLoS Pathog."},{"key":"6136_CR30","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1038\/s41564-019-0522-6","volume":"4","author":"H Wan","year":"2019","unstructured":"Wan, H. et al. The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A\/Hong Kong\/4801\/2014 vaccine strain. Nat. Microbiol. 4, 2216\u20132225 (2019).","journal-title":"Nat. Microbiol."},{"key":"6136_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35586-7","volume":"13","author":"D Stadlbauer","year":"2022","unstructured":"Stadlbauer, D. et al. Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site. Nat. Commun. 13, 7864 (2022).","journal-title":"Nat. Commun."},{"key":"6136_CR32","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.3201\/eid2308.170600","volume":"23","author":"C Ke","year":"2017","unstructured":"Ke, C. et al. Human infection with highly pathogenic avian influenza A(H7N9) virus, China. Emerg. Infect. Dis. 23, 1332\u20131340 (2017).","journal-title":"Emerg. Infect. Dis."},{"key":"6136_CR33","doi-asserted-by":"publisher","unstructured":"Aguero, M. et al. Highly pathogenic avian influenza A(H5N1) virus infection in farmed minks, Spain, October 2022. Euro. Surveill. https:\/\/doi.org\/10.2807\/1560-7917.ES.2023.28.3.2300001 (2023).","DOI":"10.2807\/1560-7917.ES.2023.28.3.2300001"},{"key":"6136_CR34","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cell.2016.05.073","volume":"166","author":"NL Kallewaard","year":"2016","unstructured":"Kallewaard, N. L. et al. Structure and function analysis of an antibody recognizing all influenza A subtypes. Cell 166, 596\u2013608 (2016).","journal-title":"Cell"},{"key":"6136_CR35","doi-asserted-by":"publisher","first-page":"28403","DOI":"10.1074\/jbc.R110.129809","volume":"285","author":"SJ Gamblin","year":"2010","unstructured":"Gamblin, S. J. & Skehel, J. J. Influenza hemagglutinin and neuraminidase membrane glycoproteins. J. Biol. Chem. 285, 28403\u201328409 (2010).","journal-title":"J. Biol. Chem."},{"key":"6136_CR36","doi-asserted-by":"publisher","first-page":"20167","DOI":"10.1073\/pnas.0809257105","volume":"105","author":"SL Sazinsky","year":"2008","unstructured":"Sazinsky, S. L. et al. Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors. Proc. Natl Acad. Sci. USA 105, 20167\u201320172 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"6136_CR37","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nm.3443","volume":"20","author":"DJ DiLillo","year":"2014","unstructured":"DiLillo, D. J., Tan, G. S., Palese, P. & Ravetch, J. V. Broadly neutralizing hemagglutinin stalk\u2013specific antibodies require Fc\u03b3R interactions for protection against influenza virus in vivo. Nat. Med. 20, 143\u2013151 (2014).","journal-title":"Nat. Med."},{"key":"6136_CR38","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1128\/AAC.01667-08","volume":"53","author":"EA Govorkova","year":"2009","unstructured":"Govorkova, E. A. et al. Susceptibility of highly pathogenic H5N1 influenza viruses to the neuraminidase inhibitor oseltamivir differs in vitro and in a mouse model. Antimicrob. Agents Chemother. 53, 3088\u20133096 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"6136_CR39","doi-asserted-by":"publisher","first-page":"6421","DOI":"10.1021\/jm100621s","volume":"53","author":"AJ Oakley","year":"2010","unstructured":"Oakley, A. J. et al. Structural and functional basis of resistance to neuraminidase inhibitors of influenza B viruses. J. Med. Chem. 53, 6421\u20136431 (2010).","journal-title":"J. Med. Chem."},{"key":"6136_CR40","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S1473-3099(20)30004-9","volume":"20","author":"MG Ison","year":"2020","unstructured":"Ison, M. G. et al. Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial. Lancet Infect. Dis. 20, 1204\u20131214 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"6136_CR41","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.it.2017.08.003","volume":"39","author":"C Henry","year":"2018","unstructured":"Henry, C., Palm, A. E., Krammer, F. & Wilson, P. C. From original antigenic sin to the universal influenza virus caccine. Trends Immunol. 39, 70\u201379 (2018).","journal-title":"Trends Immunol."},{"key":"6136_CR42","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1056\/NEJM199910283411802","volume":"341","author":"FG Hayden","year":"1999","unstructured":"Hayden, F. G. et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N. Engl. J. Med. 341, 1336\u20131343 (1999).","journal-title":"N. Engl. J. Med."},{"key":"6136_CR43","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1056\/NEJM200011023431801","volume":"343","author":"FG Hayden","year":"2000","unstructured":"Hayden, F. G. et al. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group. N. Engl. J. Med. 343, 1282\u20131289 (2000).","journal-title":"N. Engl. J. Med."},{"key":"6136_CR44","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s41591-019-0463-x","volume":"25","author":"S Ng","year":"2019","unstructured":"Ng, S. et al. Novel correlates of protection against pandemic H1N1 influenza A virus infection. Nat. Med. 25, 962\u2013967 (2019).","journal-title":"Nat. Med."},{"key":"6136_CR45","doi-asserted-by":"publisher","first-page":"108088","DOI":"10.1016\/j.celrep.2020.108088","volume":"32","author":"CS Cheung","year":"2020","unstructured":"Cheung, C. S. et al. Identification and structure of a multidonor class of head-directed influenza-neutralizing antibodies reveal the mechanism for its recurrent elicitation. Cell Rep. 32, 108088 (2020).","journal-title":"Cell Rep."},{"key":"6136_CR46","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nbt.1601","volume":"28","author":"J Zalevsky","year":"2010","unstructured":"Zalevsky, J. et al. Enhanced antibody half-life improves in vivo activity. Nat. Biotechnol. 28, 157\u2013159 (2010).","journal-title":"Nat. Biotechnol."},{"key":"6136_CR47","doi-asserted-by":"publisher","first-page":"E5944","DOI":"10.1073\/pnas.1613225113","volume":"113","author":"PE Leon","year":"2016","unstructured":"Leon, P. E. et al. Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact. Proc. Natl Acad. Sci. USA 113, E5944\u2013E5951 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"6136_CR48","doi-asserted-by":"publisher","first-page":"100718","DOI":"10.1016\/j.xcrm.2022.100718","volume":"3","author":"A Zhang","year":"2022","unstructured":"Zhang, A. et al. Hemagglutinin stalk-binding antibodies enhance effectiveness of neuraminidase inhibitors against influenza via Fc-dependent effector functions. Cell Rep. Med. 3, 100718 (2022).","journal-title":"Cell Rep. Med."},{"key":"6136_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29416-z","volume":"13","author":"D Ellis","year":"2022","unstructured":"Ellis, D. et al. Structure-based design of stabilized recombinant influenza neuraminidase tetramers. Nat. Commun. 13, 1825 (2022).","journal-title":"Nat. Commun."},{"key":"6136_CR50","doi-asserted-by":"publisher","first-page":"e0224121","DOI":"10.1128\/mBio.02241-21","volume":"12","author":"S Strohmeier","year":"2021","unstructured":"Strohmeier, S. et al. A novel recombinant influenza virus neuraminidase vaccine candidate stabilized by a measles virus phosphoprotein tetramerization domain provides robust protection from virus challenge in the mouse model. mBio 12, e0224121 (2021).","journal-title":"mBio"},{"key":"6136_CR51","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3389\/fmicb.2016.00326","volume":"7","author":"J Xue","year":"2016","unstructured":"Xue, J., Chambers, B. S., Hensley, S. E. & Lopez, C. B. Propagation and characterization of influenza virus stocks that lack high levels of defective viral genomes and hemagglutinin mutations. Front. Microbiol. 7, 326 (2016).","journal-title":"Front. Microbiol."},{"key":"6136_CR52","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","volume":"329","author":"T Tiller","year":"2008","unstructured":"Tiller, T. et al. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J. Immunol. Methods 329, 112\u2013124 (2008).","journal-title":"J. Immunol. Methods"},{"key":"6136_CR53","doi-asserted-by":"publisher","first-page":"e1007731","DOI":"10.1371\/journal.pcbi.1007731","volume":"16","author":"M Foglierini","year":"2020","unstructured":"Foglierini, M., Pappas, L., Lanzavecchia, A., Corti, D. & Perez, L. AncesTree: an interactive immunoglobulin lineage tree visualizer. PLoS Comput. Biol. 16, e1007731 (2020).","journal-title":"PLoS Comput. Biol."},{"key":"6136_CR54","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1093\/bioinformatics\/btz305","volume":"35","author":"AM Kozlov","year":"2019","unstructured":"Kozlov, A. M., Darriba, D., Flouri, T., Morel, B. & Stamatakis, A. RAxML-NG: a fast, scalable and user-friendly tool for maximum likelihood phylogenetic inference. Bioinformatics 35, 4453\u20134455 (2019).","journal-title":"Bioinformatics"},{"key":"6136_CR55","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.vaccine.2016.11.060","volume":"35","author":"CA van Baalen","year":"2017","unstructured":"van Baalen, C. A. et al. ViroSpot microneutralization assay for antigenic characterization of human influenza viruses. Vaccine 35, 46\u201352 (2017).","journal-title":"Vaccine"},{"key":"6136_CR56","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed, L. J. & Muench, H. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27, 493\u2013497 (1938).","journal-title":"Am. J. Epidemiol."},{"key":"6136_CR57","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","volume":"152","author":"DN Mastronarde","year":"2005","unstructured":"Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36\u201351 (2005).","journal-title":"J. Struct. Biol."},{"key":"6136_CR58","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/jmicro\/dfv369","volume":"65","author":"YZ Tan","year":"2016","unstructured":"Tan, Y. Z., Cheng, A., Potter, C. S. & Carragher, B. Automated data collection in single particle electron microscopy. Microscopy 65, 43\u201356 (2016).","journal-title":"Microscopy"},{"key":"6136_CR59","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/bs.mie.2016.04.012","volume":"579","author":"SH Scheres","year":"2016","unstructured":"Scheres, S. H. Processing of structurally heterogeneous cryo-EM data in RELION. Methods Enzymol. 579, 125\u2013157 (2016).","journal-title":"Methods Enzymol."},{"key":"6136_CR60","doi-asserted-by":"publisher","first-page":"e18722","DOI":"10.7554\/eLife.18722","volume":"5","author":"D Kimanius","year":"2016","unstructured":"Kimanius, D., Forsberg, B. O., Scheres, S. H. & Lindahl, E. Accelerated cryo-EM structure determination with parallelisation using GPUs in RELION-2. eLife 5, e18722 (2016).","journal-title":"eLife"},{"key":"6136_CR61","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"6136_CR62","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","volume":"192","author":"A Rohou","year":"2015","unstructured":"Rohou, A. & Grigorieff, N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216\u2013221 (2015).","journal-title":"J. Struct. Biol."},{"key":"6136_CR63","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"6136_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","volume":"193","author":"K Zhang","year":"2016","unstructured":"Zhang, K. Gctf: real-time CTF determination and correction. J. Struct. Biol. 193, 1\u201312 (2016).","journal-title":"J. Struct. Biol."},{"key":"6136_CR65","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/nmeth.2115","volume":"9","author":"SH Scheres","year":"2012","unstructured":"Scheres, S. H. & Chen, S. Prevention of overfitting in cryo-EM structure determination. Nat. Methods 9, 853\u2013854 (2012).","journal-title":"Nat. Methods"},{"key":"6136_CR66","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"6136_CR67","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"6136_CR68","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1107\/S2059798318002425","volume":"74","author":"TI Croll","year":"2018","unstructured":"Croll, T. I. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr. D Struct. Biol. 74, 519\u2013530 (2018).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"6136_CR69","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1107\/S1399004714016241","volume":"70","author":"RA Nicholls","year":"2014","unstructured":"Nicholls, R. A., Fischer, M., McNicholas, S. & Murshudov, G. N. Conformation-independent structural comparison of macromolecules with ProSMART. Acta Crystallogr. D Biol. Crystallogr. 70, 2487\u20132499 (2014).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"6136_CR70","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1107\/S2059798321009475","volume":"77","author":"K Yamashita","year":"2021","unstructured":"Yamashita, K., Palmer, C. M., Burnley, T. & Murshudov, G. N. Cryo-EM single-particle structure refinement and map calculation using Servalcat. Acta Crystallogr. D Struct. Biol. 77, 1282\u20131291 (2021).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"6136_CR71","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1107\/S1399004714021683","volume":"71","author":"A Brown","year":"2015","unstructured":"Brown, A. et al. Tools for macromolecular model building and refinement into electron cryo-microscopy reconstructions. Acta Crystallogr. D Biol. Crystallogr. 71, 136\u2013153 (2015).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"6136_CR72","unstructured":"Schr\u00f6dinger, L. D. W. PyMOL. PyMOL http:\/\/www.pymol.org\/pymol (2020)."},{"key":"6136_CR73","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41586-021-03807-6","volume":"597","author":"TN Starr","year":"2021","unstructured":"Starr, T. N. et al. SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape. Nature 597, 97\u2013102 (2021).","journal-title":"Nature"},{"key":"6136_CR74","unstructured":"Case, D. A. et al. Amber: Tools for Molecular Simulations. University of California, San Francisco. https:\/\/ambermd.org\/index.php (2023)."},{"key":"6136_CR75","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier, J. A. et al. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 11, 3696\u20133713 (2015).","journal-title":"J. Chem. Theory Comput."},{"key":"6136_CR76","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/jcc.20820","volume":"29","author":"KN Kirschner","year":"2008","unstructured":"Kirschner, K. N. et al. GLYCAM06: a generalizable biomolecular force field. Carbohydrates. J. Comput. Chem. 29, 622\u2013655 (2008).","journal-title":"J. Comput. Chem."},{"key":"6136_CR77","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926\u2013935 (1983).","journal-title":"J. Chem. Phys."},{"key":"6136_CR78","doi-asserted-by":"publisher","first-page":"9020","DOI":"10.1021\/jp8001614","volume":"112","author":"IS Joung","year":"2008","unstructured":"Joung, I. S. & Cheatham, T. E. 3rd Determination of alkali and halide monovalent ion parameters for use in explicitly solvated biomolecular simulations. J. Phys. Chem. B 112, 9020\u20139041 (2008).","journal-title":"J. Phys. Chem. B"},{"key":"6136_CR79","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1126\/science.abo7896","volume":"377","author":"TN Starr","year":"2022","unstructured":"Starr, T. N. et al. Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution. Science 377, 420\u2013424 (2022).","journal-title":"Science"},{"key":"6136_CR80","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1002\/jcc.25382","volume":"39","author":"DR Roe","year":"2018","unstructured":"Roe, D. R. & Cheatham, T. E. 3rd Parallelization of CPPTRAJ enables large scale analysis of molecular dynamics trajectory data. J. Comput. Chem. 39, 2110\u20132117 (2018).","journal-title":"J. Comput. Chem."},{"key":"6136_CR81","doi-asserted-by":"publisher","unstructured":"Yang X. et al. Defining protein variant functions using high-complexity mutagenesis libraries and enhanced mutant detection software ASMv1.0. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2021.06.16.448102 (2023).","DOI":"10.1101\/2021.06.16.448102"},{"key":"6136_CR82","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/molbev\/mst010","volume":"30","author":"K Katoh","year":"2013","unstructured":"Katoh, K. & Standley, D. M. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 30, 772\u2013780 (2013).","journal-title":"Mol. Biol. Evol."},{"key":"6136_CR83","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1093\/bioinformatics\/btx469","volume":"33","author":"O Wagih","year":"2017","unstructured":"Wagih, O. ggseqlogo: A versatile R package for drawing sequence logos. Bioinformatics 33, 3645\u20133647 (2017).","journal-title":"Bioinformatics"}],"updated-by":[{"DOI":"10.1038\/s41586-023-06385-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000}}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06136-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06136-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06136-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T03:04:14Z","timestamp":1688612654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06136-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":83,"journal-issue":{"issue":"7965","published-print":{"date-parts":[[2023,6,15]]}},"alternative-id":["6136"],"URL":"https:\/\/doi.org\/10.1038\/s41586-023-06136-y","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]},"assertion":[{"value":"19 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41586-023-06385-x","URL":"https:\/\/doi.org\/10.1038\/s41586-023-06385-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.M., H.V.D., F.Z., K.H., C.W., J.d.I., A.M., N.C., A.D.M., K.B., D.D., S.V., A.C., B.G., A.E.P., S.S.Y., D.R.B., I.B., M.M., M.A.S., W.T.S., J.L.M., E.C., A.T., L.E.R., L.A.P., A.L., G.S., D.C. and M.S.P. are employees of and may hold shares in Vir Biotechnology. D.C., M.S.P., A.M., E.C., G.S., K.H., C.M. and E.F. are currently listed as inventors on multiple patent applications, which disclose the subject matter described in this paper. E.F., A.E.P., R.S. and H.W.V. are former employees of VIR Biotechnology. E.F. is currently an employee at and hold stocks in Amgen. Amgen provided no funding for this work. T.I.C. is a consultant for Vir Biotechnology and receives royalties from licensing of ISOLDE software used for molecular modelling. D.M.B. received research funding from VIR Biotechnology. L.A.P. is a former employee and shareholder of Regeneron Pharmaceuticals and is a member of the Scientific Advisory Board AI-driven structure-enabled antiviral platform (ASAP). Regeneron provided no funding for this work. H.W.V. is a founder of PierianDx and Casma Therapeutics. Neither company provided funding for this work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}